Skip to main content
OpenTrials
Completed

NCT Number: NCT00992862

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under fasting conditions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Novum Pharmaceutical Research Services

Pittsburgh, Pennsylvania, 15206, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening

Exclusion criteria

  • Positive test results for HIV or Hepatitis B or C
  • History of allergy or sensitivity to Moexipril HCl or related drugs

Treatment and study plan

Moexipril HCl 15mg Tablets, Paddock Laboratories, Inc.

Drug

Univasc® 15mg Tablets

Drug

Primary outcomes

  1. Bioequivalence according to US FDA guidelines

Sponsors and collaborators

Lead sponsor

Paddock Laboratories, Inc.

Industry

Registry information

Official study title

A Relative Bioavailability Study of Moexipril HCl 15mg Tablets Under Fasting Conditions

Important dates

First posted
Oct 9, 2009
Registry last updated
Sep 26, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.